Stroke: Epidemiology, Risk Factors, Signaling Pathways, and Clinical Management
2025/12/01 by He Ren, Yuchun Liu, Mingyue Zhao +4 · 1 voice
Neuroscience · #Neurological Disease Mechanisms and Treatments #Neuroinflammation and Neurodegeneration Mechanisms #Neurological Disorders and Treatments
paper · doi:10.1002/mco2.70558
openalex publication_date 2025/12/01 · openalex created_date 2025/12/19 · openalex updated_date 2026/07/31
Abstract
Stroke can be classified into ischemic stroke (IS), hemorrhagic stroke (HS), and subarachnoid hemorrhage. The high incidence, disability, and mortality rates, especially from IS, place a huge burden on global health. The pathophysiological processes following IS mainly involve energy deficiency, ion homeostasis imbalance, oxidative stress, neuroinflammation, programmed cell death, blood-brain barrier disruption, and cerebral edema. Transient ischemic attack is an early warning sign of IS, characterized by temporary neurological deficits. HS mainly involves primary damage caused by the mass effect of hematoma and secondary damage caused by the toxic components of hematoma. Although advances in acute-phase reperfusion technology have reduced mortality, the fundamental challenge of a narrow therapeutic window limits patient eligibility and long-term recovery outcomes. This review aims to provide a comprehensive overview of stroke, detailing its epidemiology, risk factors, pathophysiological mechanisms, signaling pathways, and clinical management methods. Here, we focus on the latest research progress in IS and emphasize the hope that regenerative therapies, especially stem cell therapies, offer for stroke patients. This review aims to provide a detailed overview of current research and clinical practice in stroke, propose emerging strategies for treating stroke patients, and provide an outlook on future research directions in this field.
Citations
- Striatal astrocytes transdifferentiate into functional mature neurons following ischemic brain injury
- Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways
- Mitochondrial ROS-induced ROS release: An update and review
- Regional Differences in Late-Onset Iron Deposition, Ferritin, Transferrin, Astrocyte Proliferation, and Microglial Activation after Transient Forebrain Ischemia in Rat Brain
- Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
- The relation between impairments and functional outcomes poststroke
- Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke
- ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis
- Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- Ferroptosis: mechanisms, biology and role in disease
- Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
- Rural-urban differences in stroke risk
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction
- Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions
- Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities
- A Review of Exercise-Induced Neuroplasticity in Ischemic Stroke: Pathology and Mechanisms
Discussions
Related